Enzymatica AB (publ),556719-9244 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken, adress mm för Enzymatica AB
Invent Medic Sweden AB Arsredovisning 2015 såsom IP-chef på Alligator Bioscience, projektledare på Enzymatica AB samt VD på ProNoxis AB. Karin Bryder
Enzymatica AB (EZYMF) Other OTC - Other OTC Delayed Price. Currency in USD. Add to watchlist. 2.2000 0.0000 (0.00%) Fair Value is the appropriate price for the shares of a company, based on Stock analysis for Enzymatica AB (ENZY:FN Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ENZY | Complete Enzymatica AB stock news by MarketWatch.
Klik her for at følge aktiekursen i realtid Enzymatica AB: Extraordinary shareholders' meeting on changes to the board of directors. Press release Lund, 1 December 2016. The company has been informed that shareholders representing more than 50 per cent of the shares and votes of Enzymatica support the proposal. Technical analysis gauges display real-time ratings for the selected timeframes.
Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Price trends tend to persist, so it's worth looking at them when it comes to a share like Enzymatica AB (publ). Over the past six months, the relative strength of its shares against the market has been -6.94%.
Stock release 21.10.2020 12:00. Enzymatica har ingått avtal med Claus Egstrand, Chief Operating Officer Enzymatica AB Tel: +44 7780 22 8385 | E-post:
Klik her for at følge aktiekursen i realtid press release december 2, 2018 not for distribution, directly or indirectly, in or into the united states, australia, hongkong, japan, canada, switzerland, sing Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period. Enzymatica AB (publ) (EN9:DEU) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates.
Enzymatica AB (ENZY.ST) Stockholm - Stockholm Real Time Price. Currency in SEK. Add to watchlist. 10.84 +0.18 (+1.69%) At close: April 9 5:29PM CEST. Summary. Chart. Conversations.
26.3.2021. Köp av aktier: Enzymatica AB; Köp av aktier. Uppdrag; Bcreades aktie.
The company's first product is ColdZyme® Munspray, which is marketed for cold virus prophylaxis and anti-cold virus therapeutic. press release december 2, 2018 not for distribution, directly or indirectly, in or into the united states, australia, hongkong, japan, canada, switzerland, sing
Detailed technical analysis and trading signals for the Enzymatica publ AB Stock. Enzymatica meddelar idag att årsredovisningen för 2018 finns tillgänglig på bolagets hemsida www.enzymatica.se samt kan läsas via länk nedan. En engelsk kortversion av årsredovisningen finns tillgänglig på den engelskspråkiga versionen av hemsidan.
Agneta sandell
Price target in 14 days: 2.200 USD. The best long-term & short-term Enzymatica AB share price prognosis ENZYMATICA: LEDAMOT MATS K ANDERSSON KÖPT AKTIER FÖR 13 MLN KR STOCKHOLM (Nyhetsbyrån Direkt) Mats K Andersson, som är styrelseledamot i Enzymatica, har på fredagen köpt 750.000 aktier för 13 miljoner kronor i bolaget utanför han Köp aktien Enzymatica AB (ENZY). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid Enzymatica AB (publ),556719-9244 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken, adress mm för Enzymatica AB (publ) Sök Få mer bolagsinformation Enzymatica AB är ett life science-bolag som utvecklar och säljer medicintekniska produkter mot infektionsrelaterade sjukdomar. Produkterna är baserade på en barriärteknologi, som inkluderar marina enzymer.
63%.
Vad är inre lösöre
flixbus lediga jobb
ginatricot lediga jobb
epileptisk anfald kramper
söka organisationsnummer förening
Enzymatica AB is a life science company that is listed on the Nasdaq First North Growth. Market. fixed costs for both the sales organization and for market investments. throat and cold symptoms, ColdZyme has a market share of almost 60
För mer information, kontakta: Fredrik Lindberg, VD Enzymatica AB Enzymatica AB, ENZY: Overview with real-time Short Interest, Analysts Estimates, Insiders, Director Dealings, Valuation, EPS, DPS, News, Peers, Events, Short ENZYMATICA AB analysts consensus, targets, ratings and recommendations | Nasdaq Stockholm: ENZY | Nasdaq Stockholm About Enzymatica AB Enzymatica is a life science company who develops and sells medical device products against infectious-related diseases. Over a short period the company has developed a unique oral spray for colds, ColdZyme®, and launched it on six markets. The product has become one of the leading articles for colds in Swedish pharmacies. Share Price Today; ENZYMOTEC LTD. Share Price Chart; ENZYMOTEC LTD. News; Enzymatica AB: Notice of annual general meeting in Enzymatica AB (publ) 21/03/2017 3:02pm Teckning av vinstandelslån i High Yield Opportunity Fund AB (publ)2021-05-28; Inbjudan till teckning av aktier i Type1 Water AB (publ)2021-05-04; Inbjudan till teckning av vinstandelslån i Fastighetsräntefonden Tessin AB (publ)2021-04-29; Inbjudan till teckning av aktier i Brunkeberg Systems AB2021-04-28 Enzymatica publ AB is a Sweden-based company engaged in biotechnology. It researches, develops and registers enzyme-based health and wellbeing Enzymatica publ AB is a Sweden-based company engaged in biotechnology.